Ignite Creation Date:
2024-05-05 @ 12:10 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00267800
Status:
UNKNOWN
Last Update Posted:
2008-08-08
First Post:
2005-12-19
Brief Title:
Database of Interstitial Lung Diseases
Sponsor:
St Antonius Hospital
Organization:
St Antonius Hospital
Study Overview
Official Title:
Registration of Clinical Data and DNASerum of Patients With Interstitial Lung Diseases ILD
Status:
UNKNOWN
Status Verified Date:
2005-12
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The cause of most interstitial lung diseases ILDs is still unknown Further research for example to determine predisposing genetic factors is therefore needed A database with relevant clinical data and DNAserum samples of ILD patients could facilitate future research on the cause of ILDs
Detailed Description:
Protocol title Registration of clinical data and DNA of patients with Interstitial Lung Disease ILD Rationale The etiopathogenesis of most Interstitial Lung Diseases ILDs is still unknown Further research eg to determine predisposing genetic factors is therefore needed A database with relevant clinical data and DNAserum samples of ILD patients could facilitate future research on the etiopathogenesis of ILDs
Objective Availability of relevant clinical data and DNAserum samples of ILD patients in a database Those data can be used for future research
Study design A prospective observational study
Study population Patients diagnosed with ILD attending the pulmonology department in participating hospitals
Intervention a blood sample is taken from each patient Furthermore additional information is collected from the medical file
Main study parametersendpoints DNA and serum sample demographic variables medical information occupational history and hobbies
Nature and extent of the burden and risks associated with participation group relatedness two tubes of blood will be drawn from the patients The risks of drawing blood from a vein are minimal
Objective Availability of relevant clinical data and DNAserum samples of ILD patients in a database Those data can be used for future research
Study design A prospective observational study
Study population Patients diagnosed with ILD attending the pulmonology department in participating hospitals
Intervention a blood sample is taken from each patient Furthermore additional information is collected from the medical file
Main study parametersendpoints DNA and serum sample demographic variables medical information occupational history and hobbies
Nature and extent of the burden and risks associated with participation group relatedness two tubes of blood will be drawn from the patients The risks of drawing blood from a vein are minimal
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None